Furthermore, Novo Nordisk should earn important label expansions for some of its current medicines while developing new ones in other areas. Semaglutide is being tested in Alzheimer's disease. And the ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

To lose weight, Mafdali’s endocrinologist suggested GLP-1 receptor agonists: a new, enormously popular class of injectable weight-loss drugs known as semaglutides. They’re sold under brand names like ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...

The molecules found in Ozempic and Mounjaro could be the secret to curing Alzheimer’s and heart disease, explains ...

“Being part of the group is brilliant. We have met some wonderful people, been able to improve people’s knowledge of dementia and the importance of Alzheimer’s Research UK’s research. I have made some ...

Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic ...

But this doesn't negate the drugs' potential downsides, one of which has doctors urging patients to "proceed with caution" ...

Discover more ways to keep your body and mind healthy and strong against dementia.

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

Research has found that weight-loss drugs such as Ozempic may help curb addictive behaviours, such as alcohol addiction. One ...

Joe Rogan has joined the growing tribe of teetotalers. On a recent episode of “The Joe Rogan Experience,” the podcaster, 57, said he has given up drinking alcohol. “I think I’m done,” he said. “For no ...